Document Detail

Effective serological and molecular screening of deceased tissue donors.
MedLine Citation:
PMID:  23354598     Owner:  NLM     Status:  Publisher    
A comprehensive and effective screening programme is essential to support the banking of tissues from deceased donors. However, the overall quality of the samples obtained from deceased donors, quantity and condition, is often not ideal, and this may lead to problems in achieving accurate and reliable results. Additionally a significant percentage of referrals are still rejected upon receipt as unsuitable for screening. We are actively involved in improving the overall quality of deceased donor screening outcomes, and have specifically evaluated and validated both serological and molecular assays for this purpose, as well as developing a specific screening strategy to minimise the specificity issues associated with serological screening. Here we review the nature and effectiveness of the deceased donor screening programme implemented by National Health Service Blood and Transplant (NHSBT), the organisation with overall responsibility for the supply of tissue products within England. Deceased donor screening data, serological and molecular, from August 2007 until May 2012 have been collated and analysed. Of 10,225 samples referred for serology screening, 5.5 % were reported as reactive; of 2,862 samples referred for molecular screening, 0.1 % were reported as reactive/inhibitory. Overall 20 % of the serological and 100 % of the molecular screen reactivity was confirmed as reflecting true infection. The use of a sequential serology screening algorithm has resulted in a marked reduction of tissues lost unnecessarily due to non-specific screen reactivity. The approach taken by NHSBT has resulted in the development of an effective and specific approach to the screening of deceased tissue donors.
A D Kitchen; J A Newham; H L Gillan
Related Documents :
8719768 - Injectable medications for hemodialysis patients.
23060278 - Htlv-1 in solid-organ transplantation: current challenges and future management strateg...
25265508 - Clinical efficacy and safety of pamidronate therapy on bone mass density in early post-...
24591768 - Hla-g polymorphism (rs16375) and acute rejection in liver transplant recipients.
3913368 - The question of bone marrow stromal fibroblast traffic.
11891468 - Effect of the size of regions of interest on the estimation of differential renal funct...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-29
Journal Detail:
Title:  Cell and tissue banking     Volume:  -     ISSN:  1573-6814     ISO Abbreviation:  Cell Tissue Bank     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-28     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100965121     Medline TA:  Cell Tissue Bank     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
National Transfusion Microbiology Reference Laboratory, NHS Blood and Transplant, Charcot Road, Colindale Avenue, London, NW9 5BG, UK,
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Validation of the BRCA1 antibody MS110 and the utility of BRCA1 as a patient selection biomarker in ...
Next Document:  Immune effects of optimized DNA vaccine and protective effects in a MPTP model of Parkinson's diseas...